22nd Century Announces 1-for-15 Reverse Stock Split
Re-Affirms Full-Year Outlook of $105 Million to $110 Million in Net Sales
BUFFALO, N.Y., July 03, 2023 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company de…